Skip to main content
SpringerLink
Log in
Book cover

Hughes Syndrome pp 362–374Cite as

Placental Pathology in Antiphospholipid Syndrome

  • Chapter

Keywords

  • Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus Patient
  • Obstet Gynecol
  • Fetal Loss
  • Placental Villus

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Roussex RG, Kaider BD, Price DE, et al. Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol 1996;35:415–420.

    Google Scholar 

  2. Fraga M, Mintz G, Orozeo J, et al. Sterility and fertility rates, fetal wastage and maternal morbidity in SLE. J Rheumatol 1974;1:293–298.

    Google Scholar 

  3. Kaplan J. Fetal wastage in patients with rheumatoid arthritis. J Rheumatol 1986:13:875–877.

    PubMed  CAS  Google Scholar 

  4. Alarcon-Segovia D, Perez-Vasquez ME, Villa AR, et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992;21:275–285.

    CrossRef  PubMed  CAS  Google Scholar 

  5. Asherson RA, Cervera R, Piette C, Shoenfeld Y. The antiphospholipid syndrome: history, definition, classification, and differential diagnosis. In: The antiphospholipid syndrome. 1996:3–12.

    Google Scholar 

  6. Nilsson IM, Astedt B, Hedner U, et al. Intrauterine death and circulating anticoagulant “antithromboplastin.” Act Med Scand 1975;197:153–159.

    CAS  Google Scholar 

  7. Wilson A, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309–1311.

    CrossRef  PubMed  CAS  Google Scholar 

  8. Branch WD. Thoughts on the mechanism of pregnancy loss associated with antiphospholipid syndrome. Lupus 1994;3:275–280.

    PubMed  CAS  Google Scholar 

  9. Harris EN, Spinnato JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991;165:1272–1277.

    PubMed  CAS  Google Scholar 

  10. Perez MC, Wilson WA, Brown HL, et al. Anticardiolipin antibodies in unselected pregnant women in relationship to fetal outcome. J Perinatol 1991;11:33–36.

    PubMed  CAS  Google Scholar 

  11. Branch DW, Silver RM, Blackwell JC, et al. Outcomes of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614–620.

    PubMed  CAS  Google Scholar 

  12. Lubbe WF, Butler WS, Palmer SJ, et al. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983;1361–1363.

    Google Scholar 

  13. Out H, Bruinse HW, Christiaens GCML, et al. A prospective controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992;167:26–32.

    PubMed  CAS  Google Scholar 

  14. Branch DW, Porter TF, Rittenhouse L, et al. Antiphospholipid antibodies in women at risk for preeclampsia Am J Obstet Gynecol 2001;184:823–834.

    CrossRef  Google Scholar 

  15. Lie JT. Vasculitis in the antiphospholipid syndrome: culprit or consort? J Rheumatol 1994;21:397–399.

    PubMed  CAS  Google Scholar 

  16. Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G factions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990;163:210–216.

    PubMed  CAS  Google Scholar 

  17. Blank M, Cohen J, Toder V, et al. Induction of antiphospholipid syndrome by passive transfer of anticardiolipin antibodies. Proc Nat Acad Sci U S A 1991;88:3069–3073.

    CrossRef  CAS  Google Scholar 

  18. Gharavi AE, Sammaritano LR, Wen J, et al. Induction of antiphospholipid autoantibodies by immunization with B2 glycoprotein I (apolipoprotein H). J Clin Invest 1992;90:1105–1109.

    CrossRef  PubMed  CAS  Google Scholar 

  19. Blank M, Faden D, Tincani A, et al. Immunization with anticardiolipin cofactor (beta 2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmunity 1994;7:441–445.

    CrossRef  CAS  Google Scholar 

  20. McNeil HD, Simpson RJ, Chesterman CN, et al. Antiphospholipid antibodies are directed against a complex antigen that included a lipid-binding inhibitor of coagulation: beta-2-glucoprotein I (apolipoprotein H). Proc Nati Acad Sci U S A 1990;87:4120–4124.

    CrossRef  CAS  Google Scholar 

  21. Galli M, Confurius P, Massau C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544–1547.

    CrossRef  PubMed  CAS  Google Scholar 

  22. Galli M, Barbui T. Prothrombin as cofactor for antiphospholipids. Lupus 1998;7(suppl 2):S37–S40.

    CrossRef  PubMed  CAS  Google Scholar 

  23. Parke A, Maier D, Hakim C, et al. Subclinical autoimmune disease and recurrent spontaneous abortion. J Rheumatol 1986;13:1178–1180.

    PubMed  CAS  Google Scholar 

  24. McNeil HP, Hunt JE, Krilis SA. Antiphospholipid antibodies — new insights into their specificity and clinical importance. Scand J Immunol 1992;36:647–652.

    PubMed  CAS  Google Scholar 

  25. Khamashta M, et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;332:993–997.

    CrossRef  PubMed  CAS  Google Scholar 

  26. Rosove MH, Brewer P. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;17:303–308.

    Google Scholar 

  27. Crowther MA, Ginsberg JS, Julian J, et al. A Comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with antiphospholipid antibody syndrome. N Engl J Med 2003;349;1133–1138.

    CrossRef  PubMed  CAS  Google Scholar 

  28. Lockshin MD. New perspectives in the study and treatment of antiphospholipid syndrome. In: The antiphospholipid syndrome. Boca Raton, FL: CRC Press; 1996:323–329.

    Google Scholar 

  29. Parke AL. Antiphospholipid antibody syndromes. Rheum Dis Clin North Am 1989;15:275.

    PubMed  CAS  Google Scholar 

  30. Ramsey-Goldman R, Kutzer JE, Kuller LH, et al. Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprod Immunol 1992;28:195–198.

    PubMed  CAS  Google Scholar 

  31. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in habitual aborters compared to normal women and women who have never been pregnant. Arthritis Rheum 1991;34:1231–1235.

    PubMed  CAS  Google Scholar 

  32. Maclean MA, et al. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynecol 1994;101:103–106.

    CAS  Google Scholar 

  33. Panigel M. Anatomy and morphology clinic in obstetrics and gynecology. In: The human placenta. 1986:421.

    Google Scholar 

  34. Hertig AT. The overall problem in man. In: Benirschke K, ed. Comparative aspects of reproductive failure. New York: Springer-Verlag; 1986.

    Google Scholar 

  35. Boue J, Boue A, Lazar P. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous abortions Teratology 1975;12:11.

    CrossRef  PubMed  CAS  Google Scholar 

  36. Kam EPY, Gardner L, Loke YW, et al. The role of trophoblast in the physiological change in decidual spiral arteries. Human Reprod 1999;14:2131–2138.

    CrossRef  CAS  Google Scholar 

  37. Pijnenborg R, Trophoblast invasion and placentation in the human; morphological aspects. Trophoblast Res 1990;4:33–47.

    Google Scholar 

  38. Moll W, Kunzel W, Herberger J. Hemodynamic implications of hemochorial placentation. Eur J Obstet Gynecol Biol 1975;5:67–74.

    CrossRef  CAS  Google Scholar 

  39. Brosens I, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol A 1972;1:177–191.

    CAS  Google Scholar 

  40. Pijnenborg R, Bland JM, Robertson WB. The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy. Placenta 1981;2:303–315.

    PubMed  CAS  Google Scholar 

  41. Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991:98:648–655.

    PubMed  CAS  Google Scholar 

  42. Zurier RB, et al. Systemic lupus erythematosus: management during pregnancy. Obstet Gynecol 1978;51:178–180.

    PubMed  CAS  Google Scholar 

  43. Mintz G, et al. Prospective study of pregnancy in systemic lupus erythematosus: results of a multidisciplinary approach. J Rheumatol 1986;13:732–739.

    PubMed  CAS  Google Scholar 

  44. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. Arthritis Rheum 1991;34:1538–1545.

    PubMed  CAS  Google Scholar 

  45. Hayslett JP. Effect of pregnancy in patients with SLE. Am J Kidney Dis 1982;2:223–228.

    PubMed  CAS  Google Scholar 

  46. Rudnicki RD, Gresham GE, Rothfield NF. The efficacy of antimalarials in systemic lupus erythematosus. J Rheumatol 1975;2:323–330.

    PubMed  CAS  Google Scholar 

  47. The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991;342:150–154.

    Google Scholar 

  48. Grennan DM, et al. Immunological studies of the placenta in systemic lupus erythematosis. Ann Rheum Dis 1978;37:129–134.

    CrossRef  PubMed  CAS  Google Scholar 

  49. Hanly JG, Gladman DD, Rose TH, et al. Lupus pregnancy, a prospective study of placental changes. Arthritis Rheum 1998;31:358–366.

    Google Scholar 

  50. Abramowsky CR, Vegas ME, Swinehart G, et al. Decidual vasculopathy of the placenta in systemic lupus erythematosus. N Engl J Med 1980:303:668–670.

    CrossRef  PubMed  CAS  Google Scholar 

  51. Khong TY, Pearce JM, Robertson WB. Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesions. Am J Obstet Gynecol 1987;157:360.

    PubMed  CAS  Google Scholar 

  52. Out HJ, Kooijman CD, Bruinse HW, et al. Histopathological findings in placentas from patients with intrauterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991;41:179.

    CrossRef  PubMed  CAS  Google Scholar 

  53. Salafia CM, Cowchock FS. Placental pathology and antiphospholipid: a descriptive study. Am J Perinatol 1997;14:435–441.

    CrossRef  PubMed  CAS  Google Scholar 

  54. Salafia CM, Parke AL. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Clin Rheum Dis 1997;23:85–97.

    CrossRef  CAS  Google Scholar 

  55. Rosove MH, Tabsh K, Wasserstrum N, et al. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990;75:660–634.

    Google Scholar 

  56. Lowell DM, Kaplan C, Salafia CM, College of American Pathologists Conference XIX on the Examination of the Placenta. Report on the working group on the definition of structural changes associated with abnormal function in the maternal/fetal/placental unit in the second and third trimester. Arch Path Lab Med 1991;1:647.

    Google Scholar 

  57. Schousboe I. B2 glycoprotein-1: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985;66:1086–1091.

    PubMed  CAS  Google Scholar 

  58. Parke AL, Weinstein RE, Bona RD, et al. The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S. Am J Med 1992;93:49–56.

    CrossRef  PubMed  CAS  Google Scholar 

  59. Atsumi T, Khamasta MA, Ames PR, et al. Effect of ft glycoprotein-1 and human monoclonal anti-cardiolipin antibody on the protein-S/C4b-binding protein system. Lupus 1997;6:358–364.

    PubMed  CAS  Google Scholar 

  60. Meroni PL, Del Papa N, Beltrami B, et al. Modulation of endothelial cell function by antiphospholipid antibodies. Lupus 1996:5:448–450.

    PubMed  CAS  Google Scholar 

  61. Meroni PL, Raschi E, Camera M, et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 2000;15:337–340.

    CrossRef  Google Scholar 

  62. Carreras LO, Defreyn G, Machin SJ, et al. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981;i:244–246.

    CrossRef  Google Scholar 

  63. Carreras LO, Vermylen J. Lupus anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb Haemost 1982;48:38–40.

    PubMed  CAS  Google Scholar 

  64. Del Papa N, et al. Endothelial cells as a target for antiphospholipid antibodies; role of anti B2 glycoprotein-1 antibodies. Am J Reprod Immunol 1997;38:212–217.

    PubMed  Google Scholar 

  65. Del Papa N, et al. Relationship between antiphospholipid and antiendothelial antibodies III: B2 glycoprotein-1 mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995;13:179–186.

    PubMed  Google Scholar 

  66. Mclntyre JA. Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 1992;28:127–131.

    Google Scholar 

  67. La Rosa, et al. β2 Glycoprotein-1 and placental anticoagulant protein-1 in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994;21:1684–1698.

    Google Scholar 

  68. Di Simone N, Del Papa N, Raschi E, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered B2-glycoprotein 1. Arthritis Rheum 2000;42:140–150.

    CrossRef  Google Scholar 

  69. Donohoe S, Kingdom JCP, Mackie IJ. Affinity purified human antiphospholipid antibodies bind normal term placenta. Lupus 1999;8:525–531.

    CrossRef  PubMed  CAS  Google Scholar 

  70. Di Simone N, De Carolis S, Lanzone, et al. In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin releasing hormone dependent human chorionic gonadotrophin release by cultured trophoblast cells. Placenta 1995;16:75–83.

    CrossRef  PubMed  CAS  Google Scholar 

  71. Katsuragawa H, Rote NS, Inoue T, et al. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts Am J Obstet Gynecol. 1995;172:1592.

    CrossRef  PubMed  CAS  Google Scholar 

  72. Rand JH. “Annexinopathies” — a new class of diseases. N Eng J Med 1999;340:1035–1036.

    CrossRef  CAS  Google Scholar 

  73. Reutelingsperger CP, Kop JM, Hornstra G, et al. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor Xa catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids. Eur J Biochem 1988;173:171–178.

    CrossRef  PubMed  CAS  Google Scholar 

  74. Tait JF, Sakata M, McMullen BA, et al. Placental anticogulant proteins isolation and comparative characterization of four members of the lipocortin family. Biochemistry 1988;27:6268–6276.

    CrossRef  PubMed  CAS  Google Scholar 

  75. Tait JF, Gibson D, Kujikawa D. Phospholipid binding properties of human placental anticoagulant protein I, a member of the lipocortin family. Biol Chem 1989;264:7944–7949.

    CAS  Google Scholar 

  76. Conodo S, Naguchi M, Funakoshi T, et al. Inhibition of human factor VIIa tissue factor activity by placental anticoagulant protein. Thromb Res 1987;48:449–459.

    CrossRef  Google Scholar 

  77. Sammaritano LR, Gharavi AE, Soberano C, et al. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein J Clin Immun 1992;12:27–35.

    CrossRef  PubMed  CAS  Google Scholar 

  78. Calandri C, Rand JH, Anticardiolipin antibodies block placental anticoagulant protein activity. Clin Res 1990;38:427.

    Google Scholar 

  79. Lockwood CJ, Rand JII, The immunobiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Surv 1994;49:432–441.

    PubMed  CAS  Google Scholar 

  80. Andree HAM, Hermens WT, Hemker HC, et al. Displacement of factor Va by annexin V. In: Andree, ed. Phospholipid binding and anticoagulant action of Aanexin VHAM. Maastricht, The Netherlands: Universitaire Pers Maastricht; 1992:73–85.

    Google Scholar 

  81. Voges d, Berendes R, Burger A, et al. Three dimensional structure of membrane bound annexin V. A correlative electron microscopy X ray crystallography study. J Mol Biol 1994;238:199–213.

    CrossRef  PubMed  CAS  Google Scholar 

  82. Mosser G, Ravanat C, Freyssinet JM, et al. Sub domain structure of lipid bound annexin V resolved by electron image analysis. J Mol Biol 1991;217:241–245.

    CrossRef  PubMed  CAS  Google Scholar 

  83. Wang X, Campos B, Kaetzel MA, et al. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999;108;1008–1016.

    CrossRef  Google Scholar 

  84. Rand JH. Antiphospholipid antibody mediated disruption of the annexin V antithrombotic shield: a thrombotic genie mechanism of antiphospholipid syndrome. J Autoimmun 2000;15:107–113.

    CrossRef  PubMed  CAS  Google Scholar 

  85. Rand JH, et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171:1566–1572.

    PubMed  CAS  Google Scholar 

  86. Rand JH, Wu XX, Guller S, et al. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997;177:918–920.

    CrossRef  PubMed  CAS  Google Scholar 

  87. Rehrig S, Fleming SD, Anderson J, et al. Complement inhibitor, complement receptor 1 related gene/protein y-lg attenuates intestinal damage after the onset of mesenleric ischemia/reperfusion injury in mice. J Immunol 2001;167:5921–5927.

    PubMed  CAS  Google Scholar 

  88. Xu C, Mao D, Holers VM, et al. A critical role for the murine complement regulator Crry in fetal maternal tolerance. Science 2000;287:498–501.

    CrossRef  PubMed  CAS  Google Scholar 

  89. Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody induced fetal loss. J Exp Med 2002;178:66–76.

    Google Scholar 

  90. Rai R, Cohen H, Dave M, et al. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997;314:253–257.

    CAS  Google Scholar 

  91. Kutteh MD. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584–1589.

    PubMed  CAS  Google Scholar 

  92. Hughes GVR, Khamashta MA. Seronegative antiphopholipid syndrome. Ann Rheum Dis 2003;62:1127.

    CrossRef  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Rheumatic Diseases, The University of Connecticut, School of Medicine, Farmington, CT, USA

    Ann L. Parke MBBS

Authors
  1. Ann L. Parke MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Parke, A.L. (2006). Placental Pathology in Antiphospholipid Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_29

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_29

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation